• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy House Republicans ask DEA, CBP to get ‘zombie drug’ off the streets
Economy

House Republicans ask DEA, CBP to get ‘zombie drug’ off the streets

by January 16, 2023
by January 16, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

EXCLUSIVE: House Republican lawmakers are asking the Drug and Enforcement Administration (DEA) and Customs and Border Protection (CBP) to do more to get xylazine, sometimes called the ‘zombie drug,’ off streets where drug dealers are abusing the substance by combining the animal tranquilizer with fentanyl for a deadly combination, exacerbating the fentanyl crisis.

Reps. Jim Banks, R-Ind., Kat Cammack, R-Fla., and August Plfuger, R-Texas, wrote to DEA Administrator Anne Milgram and Acting CBP Commissioner Troy Miller Monday in a letter reviewed exclusively by Fox News Digital, asking the agencies to schedule xylazine, the animal tranquilizer drug, to properly recognize the drug as ‘the threat that it is.’ 

The lawmakers called government’s response so far to the damage the drug is causing is ‘wholly inadequate.’ Banks says if the White House fails to address the problem, House Republicans will introduce legislation. 

‘For once, I hope the Biden administration moves quickly to fight the deadly drug crisis in this country. If they don’t, House Republicans will introduce legislation to schedule Xylazine,’ Banks told Fox News Digital in a statement. 

‘The fentanyl crisis has already inflicted significant damage on our treatment clinics and programs, public health agencies, and our entire medical system,’ the lawmakers wrote. ‘The addition of yet another highly toxic and addictive substance to the illicit drug supply will only further escalate this crisis. It is of the utmost importance that all relevant agencies mount an active and energetic response to this emerging threat.’

‘As you may know, xylazine, also known by street names ‘tranq’ and ‘zombie drug,’ has emerged as an increasingly popular drug to combine with fentanyl to intensify drug effects and lower costs,’ the lawmakers wrote. 

‘The effects of xylazine are devastating and include severe necrotic skin ulcerations that often lead to amputation, and severe withdrawal symptoms that leave users trapped in a vicious cycle of addiction,’ they said.

According to the lawmakers, the drug is not detected by current toxicology screens, and, in cases of overdose, naloxone is not known to be effective.

A spokesperson for the DEA told Fox News Digital that the two-part process to schedule a substance has been in the works since October 2021. That process involves sending a data review to the Department of Health and Human Services (HHS) and a request to HHS for a scheduling recommendation for xylazine.

In an effort to signal to HHS DEA’s growing concern with xylazine, DEA sent supplemental information in September 2022 to the agency in hopes to accelerate the scheduling processing. DEA is still waiting on HHS to provide a scheduling recommendation. 

‘The men and women of the DEA are relentlessly working to save American lives by stopping trafficking of xylazine and other deadly synthetic drugs,’ the spokesperson said, adding that they are looking forward to the completion of HHS’ scheduling recommendation. 

The lawmakers say that significant amounts of xylazine have already been found in drug samples in 36 states and the District of Columbia. Hospitals from across the country are reporting an increase in the prevalence of the drug.

In New York City, xylazine has been found in 25% of drug samples, though health officials say the actual number is likely much higher, the lawmakers claim. One estimate, the say, done in Philadelphia in 2021 found xylazine present in over 90% of fentanyl and heroin samples.

The lawmakers are asking the DEA to start the process of scheduling xylazine, according to the Controlled Substance Act if that process has not already been started, and for further details related to what the DEA is planning to stop xylazine’s illicit use. 

According to the DEA, ‘substances are placed in their respective schedules based on whether they have a currently accepted medical use in treatment in the United States, their relative abuse potential, and likelihood of causing dependence when abused.’

The House Republicans are also asking to what extent CBP is scrutinizing shipments from China.

The agencies have until Jan. 20 to respond. 

Brianna Herlihy is a politics writer for Fox News Digital.

This post appeared first on FOX NEWS
You Might Also Like
  • Risky Business: A Review
  • Solana and Cardano: Cardano at new monthly high
  • Top Republicans call for briefing from Pentagon on Austin’s hospitalization
  • Texas bill seeks accountability for ‘rogue’ DAs who don’t prosecute crimes
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Alabama Gov. Kay Ivey sworn in for 2nd full term
next post
Biden takes swipe at Second Amendment supporters: ‘You need F-15s’ to take on the federal government

You may also like

Jordan creeps ahead of Scalise in public House GOP support...

October 10, 2023

Conservatives celebrate DeSantis dropping out and endorsing Trump: ‘Uniting the...

January 22, 2024

Pro-lifers rejoice as Planned Parenthood announces national staffing cuts

May 25, 2023

Professors Are Not “Priests of Democracy”

December 3, 2022

Arkansas Department of Education throws down gauntlet on CRT, demands...

August 22, 2023

Judge blocks Illinois law targeting crisis pregnancy centers, calling it...

August 6, 2023

GOP bill cracks down on ‘loophole’ allowing foreign donors to...

April 18, 2024

Public cost of Atlanta’s ‘Cop City’ more than doubled in...

May 30, 2023

Vance, Harris discuss debate in ‘brief and respectful’ first phone...

July 16, 2024

Insiders predict this possible Trump VP pick poses ‘existential threat’...

June 2, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Where the Market Goes Next: Key Resistance Levels + Top Bullish Stocks to Watch Now

      May 10, 2025
    • Recession Ahead? Sector Rotation Model Warns of Rising Risk

      May 10, 2025
    • Investment Portfolio Feeling Stagnant? Transform Your Path Today

      May 9, 2025
    • Confused by the Market? Let the Traffic Light Indicator Guide You

      May 9, 2025
    • Which Will Hit First: SPX 6100 or SPX 5100?

      May 9, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,633 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,339 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,321 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,303 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,186 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,536)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Where the Market Goes Next: Key Resistance Levels + Top...

      May 10, 2025
    • Recession Ahead? Sector Rotation Model Warns of Rising Risk

      May 10, 2025
    • Investment Portfolio Feeling Stagnant? Transform Your Path Today

      May 9, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,536)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Israel to continue full-scale operations in...

    February 19, 2024

    Google Gemini invented fake reviews smearing...

    February 27, 2024

    Johnson floats defunding special counsel’s office...

    May 16, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here